Hip Prosthesis Market Size, Share and Growth Outlook, 2026

Hip Prosthesis Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Hip Prosthesis Market size is forecast to increase from $4.2 Billion in 2026 to $5.08 Billion in 2034 at a CAGR of 2.4% between 2026 and 2034.

The Hip Prosthesis market report provides detailed analysis and outlook of Hip Prosthesis segments including By Product Type (Primary Hip Prosthesis, Revision Hip Prosthesis, Partial Hip Prosthesis, Hip Resurfacing Prosthesis), By Fixation Material (Cementless Fixation, Cemented Fixation, Hybrid Fixation), By Insert Type (Non-antioxidant Polyethylene Inserts, Cross-linked Polyethylene Inserts, Antioxidant Polyethylene Inserts), By End User (Hospitals and Clinics, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Hip Prosthesis Industry Overview

Advanced Acetabular Technologies Improve Outcomes in Complex Hip Reconstruction

The hip prosthesis industry continues to evolve through innovations focused on implant stability, anatomical compatibility, and long-term performance in both primary and revision hip replacement procedures. Zimmer Biomet Holdings, Inc. strengthened its orthopedic portfolio after receiving U.S. Food and Drug Administration 510(k) clearance for its next-generation G7 Acetabular System. The advanced hip prosthesis integrates the company’s porous Trabecular Metal Technology with anatomically derived screw hole configurations designed to enhance fixation in compromised bone structures. The system is specifically engineered to address the challenges associated with complex primary and revision hip arthroplasty cases, where achieving initial construct stability is critical for long-term success. Growing demand for advanced acetabular reconstruction technologies is encouraging manufacturers to invest in biomaterial innovations and patient-specific design features that improve implant integration and support durable clinical outcomes.

Minimally Invasive Surgical Approaches Drive Hip Prosthesis Adoption

The increasing preference for minimally invasive orthopedic procedures is shaping product development and commercial strategies across the hip prosthesis market. Medacta reported strong growth within its hip portfolio, primarily driven by the expanding adoption of its Anterior Minimally Invasive Surgery platform. The technique is gaining acceptance among orthopedic surgeons due to its potential to reduce soft tissue disruption and support faster patient recovery. To meet rising global demand for its hip prosthesis products, the company completed a fully automated logistics and warehouse expansion in Italy. This infrastructure investment enhances supply chain efficiency and strengthens production support for orthopedic implant distribution. The growing popularity of minimally invasive hip replacement procedures continues to influence implant design, surgical instrumentation development, and operational investments throughout the global hip prosthesis industry.

Surgeon Training and Customized Implant Designs Enhance Clinical Performance

Education and procedural optimization are becoming increasingly important components of the hip prosthesis industry. MicroPort Orthopedics completed extensive multi-regional training programs focused on its advanced total hip prosthesis systems. The initiative emphasizes tissue-sparing surgical techniques and the use of customized femoral stem designs engineered to improve rotational stability while reducing the likelihood of post-operative dislocation. As healthcare providers increasingly prioritize patient outcomes and procedural precision, manufacturers are investing in surgeon education programs that support standardized implant deployment and best-practice surgical methodologies. The combination of advanced implant engineering and specialized clinical training reflects the industry's commitment to improving mobility restoration, reducing complication rates, and enhancing the overall success of total hip replacement procedures.

Hip Prosthesis Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Hip Prosthesis market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zimmer Biomet Holdings, Inc., Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, Exactech, Inc., Corin Group, MicroPort Scientific Corporation, Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, Conformis, Inc.. The Hip Prosthesis market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Hip Prosthesis industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Hip Prosthesis Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Hip Prosthesis companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Hip Prosthesis markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Hip Prosthesis Market Competitive Benchmarking and Company Analysis

Leading companies in Hip Prosthesis industry include- Zimmer Biomet Holdings, Inc., Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, Exactech, Inc., Corin Group, MicroPort Scientific Corporation, Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, Conformis, Inc.. The Hip Prosthesis market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Hip Prosthesis Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Hip Prosthesis market remains one of the strongest-performing segments in the country.
The US Hip Prosthesis Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Hip Prosthesis market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Hip Prosthesis industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Hip Prosthesis markets

Canada's strong Hip Prosthesis sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Hip Prosthesis market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Hip Prosthesis Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Hip Prosthesis market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Hip Prosthesis population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Hip Prosthesis industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Hip Prosthesis market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Hip Prosthesis sales through 2034

France Hip Prosthesis companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Hip Prosthesis Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Hip Prosthesis distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Hip Prosthesis Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Hip Prosthesis market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Hip Prosthesis industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Hip Prosthesis industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Hip Prosthesis Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Hip Prosthesis market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Hip Prosthesis market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Hip Prosthesis Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Hip Prosthesis Market Segmentation

By Product Type
Primary Hip Prosthesis
Revision Hip Prosthesis
Partial Hip Prosthesis
Hip Resurfacing Prosthesis
By Fixation Material
Cementless Fixation
Cemented Fixation
Hybrid Fixation
By Insert Type
Non-antioxidant Polyethylene Inserts
Cross-linked Polyethylene Inserts
Antioxidant Polyethylene Inserts
By End User
Hospitals and Clinics
Ambulatory Surgical Centers

Top Companies in Hip Prosthesis Industry

Zimmer Biomet Holdings, Inc.
Stryker Corporation
DePuy Synthes (Johnson & Johnson)
Smith & Nephew plc
Exactech, Inc.
Corin Group
MicroPort Scientific Corporation
Waldemar Link GmbH & Co. KG
United Orthopedic Corporation
Conformis, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025